CG
MGNX icon

Cutler Group’s MacroGenics MGNX Stock Holding History

Cutler Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-756
Closed -$15K – 5803
2021
Q3 		$15K Buy
+756
New +$18.2K ﹤0.01% 3599
2020
Q1 		– Sell
-200
Closed -$2K – 4408
2019
Q4 		$2K Hold
200
– – ﹤0.01% 3467
2019
Q3 		$2K Buy
+200
New +$2.88K ﹤0.01% 3504
2018
Q1 		– Sell
-800
Closed -$19.4K – 4923
2017
Q4 		$15K Sell
800
-500
-38% -$9.33K ﹤0.01% 2814
2017
Q3 		$24K Sell
1,300
-1,320
-50% -$22.9K ﹤0.01% 2959
2017
Q2 		$45K Sell
2,620
-1,707
-39% -$32.6K ﹤0.01% 2596
2017
Q1 		$80K Sell
4,327
-685
-14% -$13.2K ﹤0.01% 1950
2016
Q4 		$102K Buy
5,012
+4,812
+2,406% +$121K ﹤0.01% 1888
2016
Q3 		$5K Sell
200
-1,631
-89% -$48.5K ﹤0.01% 4955
2016
Q2 		$49K Sell
1,831
-4,969
-73% -$112K ﹤0.01% 2372
2016
Q1 		$127K Buy
6,800
+6,700
+6,700% +$128K 0.01% 1383
2015
Q4 		$3K Buy
+100
New +$3.04K ﹤0.01% 5313

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cutler Group's MGNX Position: Q4 2021 in Review

Cutler Group sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 756 shares — an estimated $15K sold.

Cutler Group first reported a position in MGNX in Q4 2015 and held it in 12 quarters. The position peaked at $127K in Q1 2016. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • Cutler Group reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 756 MacroGenics shares in Q4 2021, an estimated $15K.
  • Cutler Group first reported a position in MacroGenics in Q4 2015 and held it in 12 quarters.
  • Cutler Group's MacroGenics position peaked at $127K in Q1 2016.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.